ArticleFrontiers in pharmacology2024

A pharmacovigilance study of chronic kidney disease in diabetes mellitus patients with statin treatment by using the US Food and Drug Administration adverse event reporting system.

Jingyi Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.